A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilic syndromes.
about
Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib responseResponse to imatinib mesylate in patients with hypereosinophilic syndrome.Successful treatment with low-dose imatinib mesylate of therapy-related myeloid neoplasm harboring TEL-PDGFRB in a patient with acute promyelocytic leukemia.Imatinib for the treatment of hypereosinophilic syndromes.Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndrome.
P2860
A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilic syndromes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
A short low-dose imatinib tria ...... n hypereosinophilic syndromes.
@en
A short low-dose imatinib tria ...... n hypereosinophilic syndromes.
@nl
type
label
A short low-dose imatinib tria ...... n hypereosinophilic syndromes.
@en
A short low-dose imatinib tria ...... n hypereosinophilic syndromes.
@nl
prefLabel
A short low-dose imatinib tria ...... n hypereosinophilic syndromes.
@en
A short low-dose imatinib tria ...... n hypereosinophilic syndromes.
@nl
P2093
P1476
A short low-dose imatinib tria ...... n hypereosinophilic syndromes.
@en
P2093
Alessandra Carobbio
Alessandro M Vannucchi
Alessandro Rambaldi
Eros Di Bona
Federica Delaini
Giuseppe Rossi
Orietta Spinelli
Renato Bassan
Sara Acerboni
Silvia Mappa
P304
P356
10.1111/J.1365-2141.2009.07893.X
P407
P577
2009-09-04T00:00:00Z